These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 9815570
21. Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival. Volm M, Koomägi R. Br J Cancer; 2000 May; 82(10):1747-54. PubMed ID: 10817513 [Abstract] [Full Text] [Related]
28. p21 (WAF1/CIP1) protein expression is associated with prolonged survival but not with p53 expression in epithelial ovarian carcinoma. Schmider A, Gee C, Friedmann W, Lukas JJ, Press MF, Lichtenegger W, Reles A. Gynecol Oncol; 2000 May; 77(2):237-42. PubMed ID: 10785471 [Abstract] [Full Text] [Related]
29. Recurrent chromosomal imbalances in nonsmall cell lung carcinoma: the association between 1q amplification and tumor recurrence. Tai AL, Yan WS, Fang Y, Xie D, Sham JS, Guan XY. Cancer; 2004 May 01; 100(9):1918-27. PubMed ID: 15112273 [Abstract] [Full Text] [Related]
30. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival. Aaltomaa S, Lipponen P, Ala-Opas M, Eskelinen M, Syrjänen K, Kosma VM. Br J Cancer; 1999 Aug 01; 80(12):2001-7. PubMed ID: 10471053 [Abstract] [Full Text] [Related]
31. Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping. Riquet M, Foucault C, Berna P, Assouad J, Dujon A, Danel C. Ann Thorac Surg; 2006 Jun 01; 81(6):1988-95. PubMed ID: 16731118 [Abstract] [Full Text] [Related]
36. The prognostic significance of p53, p21 (Waf1/Cip1), and cyclin D1 protein expression in esophageal cancer patients. Hirai T, Kuwahara M, Yoshida K, Osaki A, Toge T. Anticancer Res; 1999 Jun 01; 19(5C):4587-91. PubMed ID: 10650815 [Abstract] [Full Text] [Related]
38. Correlation among six biologic factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and clinical outcomes after curative chemoradiation therapy in squamous cell cervical cancer. Yamashita H, Murakami N, Asari T, Okuma K, Ohtomo K, Nakagawa K. Int J Radiat Oncol Biol Phys; 2009 Jul 15; 74(4):1165-72. PubMed ID: 19101092 [Abstract] [Full Text] [Related]